Avelumab first-line (1L) maintenance therapy in advanced urothelial carcinoma: Final analysis from a real-world study in the UK

Item

Avelumab first-line (1L) maintenance therapy in advanced urothelial carcinoma: Final analysis from a real-world study in the UK

Jones, R. J.
;
Shah, Y.
;
Birtle, A. J.
;
Challapalli, A.
;
Chan, J.
;
Enting, D.
;
Hudson, A.
;
Linch, M. D.
;
Otter, S.
;
Protheroe, A.
... show 5 more

Citations

Google Scholar:

Altmetric:

Authors

Jones, R. J.
Shah, Y.
Birtle, A. J.
Challapalli, A.
Chan, J.
Enting, D.
Hudson, A.
Linch, M. D.
Otter, S.
Protheroe, A.
Sharma, A.
Turner, R.
Prakashbabu, B. C.
Rice, W.
Jedy-Agba, E. E.

Affiliation

Univ Glasgow, Sch Canc Sci, Glasgow, Scotland Merck Serono, Feltham, England Lancs Teaching Hosp, Rosemere Canc Ctr, Preston, England Univ Cent Lancashire, Univ Manchester, Preston, England Univ Hosp Bristol & Weston NHS Fdn Trust, Bristol Haematol & Oncol Ctr, Bristol, England Clatterbridge Canc Ctr NHS Fdn Trust, Liverpool, England Guys & St Thomas NHS Fdn Trust, London, England Christie NHS Fdn Trust, Manchester, England UCL, Canc Inst, London, England Royal Surrey Cty Hosp NHS Fdn Trust, Guildford, England Oxford Univ Hosp NHS Fdn Trust, Oxford, England Mt Vernon Canc Ctr, Northwood, England Beatson West Scotland Canc Ctr, Glasgow, Scotland IQVIA, London, England

Date

2025

Collections

All Christie Publications

Show all metadata

Type

Meetings and Proceedings

Citation

Jones RJ, Shah Y, Birtle AJ, Challapalli A, Chan J, Enting D, et al. Avelumab first-line (1L) maintenance therapy in advanced urothelial carcinoma: Final analysis from a real-world study in the UK. JOURNAL OF CLINICAL ONCOLOGY. 2025 FEB 10;43(5_SUPPL). PubMed PMID: WOS:001454740800023. English.

URI

https://christie.openrepository.com/handle/10541/627538